From the Research
Relationship between Pure Red Cell Aplasia and Systemic Lupus Erythematosus (SLE)
The relationship between pure red cell aplasia (PRCA) and systemic lupus erythematosus (SLE) is characterized by:
- PRCA being a rare cause of anemia associated with SLE 1, 2, 3, 4, 5
- The development of PRCA may be mediated by an autoimmune mechanism, supported by the presence of antibodies that impair erythropoiesis 4, 5
- The association of PRCA with immunological disorders, such as SLE, and the favorable response to immunosuppressive drugs 1, 2, 3, 4
Clinical Presentation and Treatment
Key aspects of the clinical presentation and treatment of PRCA in SLE patients include:
- Severe anemia, which may be refractory to conventional treatment 2, 3
- Response to immunosuppressive therapies, such as prednisolone, rituximab, and cyclophosphamide 1, 2, 3
- The potential use of plasmapheresis to remove autoantibodies and achieve complete normalization of erythropoiesis 4
- The detection of antibodies to erythropoietin, which may contribute to the pathogenesis of SLE-associated PRCA 5
Pathogenesis
The pathogenesis of PRCA in SLE patients may involve: